{
    "2021-10-29": [
        [
            {
                "time": "",
                "original_text": "沃森生物第三季度净利润同比下滑逾8成 mRNA疫苗商业化进程最关注 盈利能力下降",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "第三季度",
                        "净利润",
                        "下滑",
                        "mRNA疫苗",
                        "商业化",
                        "盈利能力"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "沃森生物，深不见底?",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "深不见底"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "国产新冠疫苗迎“收获期”，龙头企业第三季度业绩暴涨",
                "features": {
                    "keywords": [
                        "国产",
                        "新冠疫苗",
                        "收获期",
                        "龙头企业",
                        "第三季度",
                        "业绩",
                        "暴涨"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "沃森生物跌4.96% 中信证券上月初喊买入",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "跌",
                        "中信证券",
                        "买入"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "沃森生物(300142.SZ)半日收跌4.27% Q3净利润同比下降87.92% 盈利能力下降",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "收跌",
                        "Q3",
                        "净利润",
                        "下降",
                        "盈利能力"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "新疫苗获批叠加业绩增长130% 康泰生物股价为何开启“下跌模式”",
                "features": {
                    "keywords": [
                        "新疫苗",
                        "获批",
                        "业绩增长",
                        "康泰生物",
                        "股价",
                        "下跌模式"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "mixed",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "中信建投医药大健康团队最新研究",
                "features": {
                    "keywords": [
                        "中信建投",
                        "医药",
                        "大健康",
                        "研究"
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "HPV疫苗一针难求，国内已有16款在研",
                "features": {
                    "keywords": [
                        "HPV疫苗",
                        "一针难求",
                        "国内",
                        "在研"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}